Adial Pharmaceuticals, Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-05: Form 10-K; Period of report 2025-12-31; Description ANNUAL REPORT; Document ea0279150-10k_adial.htm.
- 2025-03-04: Form 10-K; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0232194-10k_adial.htm.
- 2024-04-01: Form 10-K; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0202434-10k_adial.htm.
- 2023-03-30: Form 10-K; Period of report 2022-12-31; Description ANNUAL REPORT; Document f10k2022_adialpharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-05 | 10-K | 2025-12-31 | ANNUAL REPORT | ea0279150-10k_adial.htm |
| 2025-03-04 | 10-K | 2024-12-31 | ANNUAL REPORT | ea0232194-10k_adial.htm |
| 2024-04-01 | 10-K | 2023-12-31 | ANNUAL REPORT | ea0202434-10k_adial.htm |
| 2023-03-30 | 10-K | 2022-12-31 | ANNUAL REPORT | f10k2022_adialpharma.htm |
| 2022-03-28 | 10-K | 2021-12-31 | ANNUAL REPORT | f10k2021_adialpharma.htm |
| 2021-03-22 | 10-K | 2020-12-31 | ANNUAL REPORT | f10k2020_adialpharmaceutical.htm |
| 2020-03-20 | 10-K | 2019-12-31 | ANNUAL REPORT | f10k2019_adialpharma.htm |
| 2019-02-19 | 10-K | 2018-12-31 | ANNUAL REPORT | f10k2018_adialpharma.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |